MedTrace Logo

Memantine Treatment of Compulsive Buying

NCT00830375 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-07-29

Study results available
· View outcomes & findings →

Summary

This is an 8-week, open-labe study of memantine in the treatment of compulsive buying.

Conditions

  • Compulsive Buying

Interventions

DRUG

Memantine

10-30mg, by mouth, daily

Sponsors & Collaborators

Principal Investigators

  • Jon Grant, MD · University of Minnesota

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-01
Primary Completion
2010-08-01
Completion
2010-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00830375 on ClinicalTrials.gov